Latest Intelligence on Diagnostic Devices and Imaging

Published within

« | 1 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Becton Dickinson: assay could improve MRSA treatment

The FDA has approved BD Diagnostics' StaphSR assay, which enables the rapid detection of Staphylococcus aureus and MRSA. Since the assay distinguishes between resistant and susceptible strains, its use will enable the faster administration of effective therapy, thereby preventing the spread of resistance and helping hospitals to reduce costs.

Published By Datamonitor
03 Jan 2008
CommentWire
CommentWire

Bristol-Myers Squibb: makes move to cut costs

Bristol-Myers Squibb has agreed to the sale of its medical imaging unit to a leading private equity firm in a $525 million transaction, two weeks after announcing plans to reduce its workforce by 10%, to concentrate resources on strengthening R&D productivity. BMS faces several key patent expiries at the end of the decade, and will rely on new launches to offset losses from its older products.

Published By Datamonitor
19 Dec 2007
CommentWire
CommentWire

ChemGenex: leukemia drug setback proves importance of diagnostics

Despite evidence of Omapro's efficacy in chronic myeloid leukemia patients, the FDA's oncology advisory committee has voted that a mutation assay should be reviewed before the regulator approves the drug. This underlines the importance of developing validated diagnostics to ensure consistent patient selection in the era of personalized medicine.

Published By Datamonitor
24 Mar 2010
Expert View
Expert View

Intel's health guide puts telehealth in the spotlight

Intel has entered the healthcare market in full force with the announcement of its Intel Health Guide product. However, a closer look at the 'personal health system' reveals it to be something of a disappointment. Although Intel's entrance into the telehealth space will bring much needed attention to the emerging technology, the company's success in this competitive new arena remains to be seen.

Published By Datamonitor
13 Nov 2008
CommentWire
CommentWire

Nosocomial infections: Medicare move creates opportunities for diagnostics

Medicare will no longer reimburse hospitals for the treatment of some preventable conditions, including certain infections acquired in healthcare facilities. This strong incentive to reduce nosocomial infection rates may well discourage pharmaceutical companies from developing premium antibiotics while giving diagnostic companies the green light they have been waiting for.

Published By Datamonitor
22 Aug 2007

« | 1 | » »|

No help is available.